Immunity Test System Suppliers In Usa

Since 2014, we have led the effort to improve children's lives with polymeric transcatheter valves (PTV) for children. PTVs are easy to manufacture in pediatric and adult sizes, expandable to accommodate growth of children, and reduces a need for ...

We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19. Cancer is genetically diverse, highly adaptive, constantly mutating and virtually invisible to ...

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity ...

We are developing the next generation of bio-therapeutics for the treatment of autoimmunity and cancer. Recent breakthroughs in the field of immunology and immuno-oncology have opened the way for a new wave of transformative treatments. Despite ...

Privately-owned company operating in Madison, Wisconsin (MG&E Innovation Center) and Chicago, Illinois. Team of experts in the field of stem cell research which allows RMS to make unprecedented scientific breakthroughs. Extensive experience in stem ...

Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...

window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded Adaptive to meet the worldwide demand for immunosequencing technology. Over the past decade, we have developed our proprietary ...

Satisform is a French scientific company specializing in research on degenerative diseases. It designs and manufactures innovative biomechanical equipment for functional rehabilitation, prevention of musculoskeletal disorders (MSDs), recovery and ...

Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...

Capricor is Developing Transformative Cell and Exosome-based Therapeutics for the Treatment and Prevention of Diseases. Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and ...

For over 25 years, OMNi-BiOTiC® has been a leading professional probiotic brand in Europe. In 2019, our dedicated team based in New York introduced Omni-Biotic to the United States. Our targeted Omni-Biotic blends developed for stress, immunity, ...

ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...

TVAX Biomedical is a clinical stage development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. TVAX Biomedical is developing a paradigm-shifting cancer treatment that offers the promise of improved ...

Kaio's strategy is to develop and in-license technologies and therapies that enable the body’s own immune system to work more efficiently. The goal is to improve clinical outcomes for patients, increase the number and efficacy of therapeutic options ...

VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP ...

We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing ...

Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. This test has not yet been ...

In 1904, Emil Haefely founded Haefely AG. Based on a patented design for manufacturing resin-impregnated paper insulators, the company grew fast and expanded into high voltage testing in 1922. Over the years, Mr. Haefely became a specialist in the ...

Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...